Zobrazeno 1 - 10
of 443
pro vyhledávání: '"Steven M Devine"'
Autor:
William A Wood, Deepika Dilip, Andriy Derkach, Natalie S Grover, Olivier Elemento, Ross Levine, Gita Thanarajasingam, John A Batsis, Charlotte Bailey, Arun Kannappan, Steven M Devine, Andrew S Artz, Jennifer A Ligibel, Ethan Basch, Erin Kent, Jacob Glass
Publikováno v:
PLOS Digital Health, Vol 2, Iss 1, p e0000178 (2023)
Clinical performance status is designed to be a measure of overall health, reflecting a patient's physiological reserve and ability to tolerate various forms of therapy. Currently, it is measured by a combination of subjective clinician assessment an
Externí odkaz:
https://doaj.org/article/e0deabaf558f4a148b9ed629f56db538
Autor:
Avirup Guha, Lai Wei, Sumithira Vasu, Daniel Addison, Jonathan E Brammer, Zachary Braunstein, Aashish Katapadi, Kyle Porter, Michael Biersmith, Vedat O Yildiz, Sakima A Smith, Benjamin Buck, Devin Haddad, Richard Gumina, Basem M William, Sam Penza, Ayman Saad, Nathan Denlinger, Ajay Vallakati, Ragavendra Baliga, Raymond Benza, Philip Binkley, Mason Mocarski, Steven M Devine, Samantha Jaglowski
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/0549dc4da85f4345b069b254b508c05d
Autor:
Kechang Liu, Bryan A Anthony, Martha M Yearsly, Mehdi Hamadani, Alice Gaughan, Jiao-Jing Wang, Steven M Devine, Gregg A Hadley
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21968 (2011)
Graft-versus-host disease (GVHD) remains the main barrier to broader application of allogeneic hematopoietic stem cell transplantation (alloSCT) as a curative therapy for host malignancy. GVHD is mediated by allogeneic T cells directed against histoc
Externí odkaz:
https://doaj.org/article/25ab7c600fff45da8d4ed178a07054c0
Autor:
Steven M Devine, Stephanie Bo-Subait, Michelle Kuxhausen, Stephen R. Spellman, Caitrin Bupp, Kwang Woo Ahn, Heather E Stefanski, Jeffery J. Auletta, Brent R Logan, Bronwen E Shaw
Publikováno v:
Blood Advances.
At the onset of the COVID-19 pandemic, the National Marrow Donor Program mandated the cryopreservation of hematopoietic cell grafts from volunteer unrelated donors due to numerous patient and donor safety concerns and logistical hurdles. Using the Ce
Autor:
Jianhua Yu, Craig C. Hofmeister, Xue-Feng Bai, Xiaoming He, Steven M. Devine, Qi-En Wang, Chang-Hyuk Kwon, Ling Yi, Tiffany Hughes, Yong Peng, Jianying Zhang, Youcai Deng, Shun He, Jianhong Chu
PDF file - 1721KB, Detailed methods for cell culture, retroviral transfection, generation of RPMI-8226 cells expressing CS1. Figure S1, killing of 293T cells expressing CS1. Figure S2, activation of T cell subsets. Figure S3, IM-9 in vivo experiment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a17ec8a17202f47929f404574758291d
https://doi.org/10.1158/1078-0432.22451724
https://doi.org/10.1158/1078-0432.22451724
Autor:
Jianhua Yu, Craig C. Hofmeister, Xue-Feng Bai, Xiaoming He, Steven M. Devine, Qi-En Wang, Chang-Hyuk Kwon, Ling Yi, Tiffany Hughes, Yong Peng, Jianying Zhang, Youcai Deng, Shun He, Jianhong Chu
Purpose: Our goal is to test whether CS1 could be targeted by chimeric antigen receptor (CAR) T cells to treat multiple myeloma (MM).Experimental Design: We generated a retroviral construct of a CS1-specific CAR and engineered primary human T cells e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5f95c239099586c82ef9d24fa24868
https://doi.org/10.1158/1078-0432.c.6522267.v1
https://doi.org/10.1158/1078-0432.c.6522267.v1
Autor:
Monzr M. Al Malki, Steven M Devine, Bronwen E. Shaw, Larisa Broglie, Muna Qayed, Sung W. Choi, Stephen R. Spellman, Craig Malmberg, Eric Ndifon, Brent Logan, Jeffery Auletta, Heather E Stefanski, Janelle A. Olson, Antonio Jimenez Jimenez
Publikováno v:
Blood. 140:7591-7593
Autor:
Heather E Stefanski, Stephanie Bo-Subait, Hati Kobusingye, Deborah Mattila, Michelle Kuxhausen, Jennifer Schenfeld, Darcie Sandschafer, Cisio De Oliveira Brandao, Linda J Burns, Bronwen E. Shaw, Michael A. Pulsipher, John P Miller, Steven M Devine
Publikováno v:
Blood. 140:10862-10864
Autor:
Monique M. Jöris, Alexander H. Schmidt, Stefanie N. Bernas, Jay Feinberg, Nicoletta Sacchi, Heidi Elmoazzen, Diane Fournier, Fatma Oguz, Danielli Oliveira, Kuo-Liang Yang, Seied Asadullah Mousavi, Soraya Moomivand, Manuel Abecasis, Juliana Villa, Mirjam M. Fechter, Guldane Cengiz Seval, Thaneya Jeyarajah, Steven M. Devine, Bronwen E. Shaw, Pablo Galarza, Richard Malan, Christopher Harvey, Stephen J. Forman, Lydia Foeken
Publikováno v:
Bone Marrow Transplantation. 57:1021-1024
Autor:
Scott R. Solomon, Richard J. O'Reilly, Sergio Giralt, Raquel Palencia, Lori Muffly, Leyla Shune, Miguel-Angel Perales, Brent R. Logan, Mary M. Horowitz, Marcelo C. Pasquini, Nancy L. Geller, Richard J. Jones, Leo Luznik, Adam Mendizabal, Sumithira Vasu, Juan Wu, Johannes Schetelig, Steven M. Devine, Helen E. Heslop, Lynn O'Donnell, Eneida R. Nemecek, Mark R. Litzow, Robert J. Soiffer, Vincent T. Ho
Publikováno v:
J Clin Oncol
PURPOSE Calcineurin inhibitors (CNI) are standard components of graft-versus-host disease (GVHD) prophylaxis after hematopoietic cell transplantation (HCT). Prior data suggested that CNI-free approaches using donor T-cell depletion, either by ex vivo